These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 52838)

  • 21. Induction of neoplastic transformation and DNA single-strand breaks in C3H/10T1/2 clone 8 cells by polycyclic hydrocarbons and alkylating agents.
    Lubet RA; Kiss E; Gallagher MM; Dively C; Kouri RE; Schechtman LM
    J Natl Cancer Inst; 1983 Nov; 71(5):991-7. PubMed ID: 6316014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo genotoxicity of EMS: statistical assessment of the dose response curves.
    Gocke E; Wall M
    Toxicol Lett; 2009 Nov; 190(3):298-302. PubMed ID: 19857797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defects in base excision repair combined with elevated intracellular dCTP levels dramatically reduce mutation induction in yeast by ethyl methanesulfonate and N-methyl-N'-nitro-N-nitrosoguanidine.
    Kunz BA; Henson ES; Karthikeyan R; Kuschak T; McQueen SA; Scott CA; Xiao W
    Environ Mol Mutagen; 1998; 32(2):173-8. PubMed ID: 9776180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unexpected genetic toxicity to rodents of the N',N'-dimethyl analogues of MNU and ENU.
    Tinwell H; Paton D; Guttenplan JB; Ashby J
    Environ Mol Mutagen; 1996; 27(3):202-10. PubMed ID: 8625956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncogenic transformation and mutation of C3H/10T 1/2 clone 8 mouse embryo fibroblasts by alkylating agents.
    Peterson AR; Landolph JR; Peterson H; Spears CP; Heidelberger C
    Cancer Res; 1981 Aug; 41(8):3095-9. PubMed ID: 7248967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Modifying action of carbamoylation reaction on mutagenic and toxic effects of alkylating compounds and heavy metal salts].
    Sal'nikova LE; Pashin IuV
    Genetika; 1988 Nov; 24(11):2088-90. PubMed ID: 3234752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular approaches to the study of chemical mutagenesis.
    Palombo F; Calcagnile A; Dogliotti E
    Ann Ist Super Sanita; 1989; 25(4):557-61. PubMed ID: 2631622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotoxic effects in human lymphocytes exposed to arsenic and vitamin A.
    Avani G; Rao MV
    Toxicol In Vitro; 2007 Jun; 21(4):626-31. PubMed ID: 17307329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on chemical carcinogens and mutagens. XXXV. Standardization of mutagenic capacities of several common alkylating agents based on the concentration-time integrated dose.
    Hakura A; Mizuno Y; Goto M; Kawazoe Y
    Chem Pharm Bull (Tokyo); 1986 Feb; 34(2):775-80. PubMed ID: 3518970
    [No Abstract]   [Full Text] [Related]  

  • 30. Validation of Drosophila melanogaster as an in vivo model for genotoxicity assessment using modified alkaline Comet assay.
    Siddique HR; Chowdhuri DK; Saxena DK; Dhawan A
    Mutagenesis; 2005 Jul; 20(4):285-90. PubMed ID: 15899934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA alkylation studies of combined treatment with methylnitrosourea and ethylmethanesulfonate in mice.
    Platzek T; Bochert G
    Teratog Carcinog Mutagen; 2000; 20(1):27-34. PubMed ID: 10607375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modelling of patient EMS exposure: translating pharmacokinetics of EMS in vitro and in animals into patients.
    Lavé T; Paehler A; Grimm HP; Gocke E; Müller L
    Toxicol Lett; 2009 Nov; 190(3):310-6. PubMed ID: 19695316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of three aziridine alkylating compounds on the gross development of chicken embryos.
    Younger RL
    Toxicol Appl Pharmacol; 1973 Mar; 24(3):423-33. PubMed ID: 4122266
    [No Abstract]   [Full Text] [Related]  

  • 34. Proceedings: Structure-activity considerations of alkylating agents as mutagens.
    Bedford CT
    Mutat Res; 1975 Aug; 29(2):195-6. PubMed ID: 1186717
    [No Abstract]   [Full Text] [Related]  

  • 35. Current status of the host-mediated L5178Y system for detecting chemical mutagens.
    Lee SY
    Environ Health Perspect; 1973 Dec; 6():145-9. PubMed ID: 4360723
    [No Abstract]   [Full Text] [Related]  

  • 36. Estimating maximum limits to mutagenic potency from cytotoxic potency.
    Carver JH; Hatch FT; Branscomb EW
    Nature; 1979 May; 279(5709):154-6. PubMed ID: 440419
    [No Abstract]   [Full Text] [Related]  

  • 37. Mode of action of alkylating agents: formation of S-ethylcysteine from ethyl methanesulphonate in vivo.
    ROBERTS JJ; WARWICK GP
    Nature; 1957 Jun; 179(4571):1181-2. PubMed ID: 13440933
    [No Abstract]   [Full Text] [Related]  

  • 38. Proceedings: Mutational response of mouse lymphoma cells in vitro to mono- and bifunctional alkylating agents.
    Fox M
    Mutat Res; 1975 Aug; 29(2):197. PubMed ID: 1237785
    [No Abstract]   [Full Text] [Related]  

  • 39. Proceedings: The use of yeast genetic systems in environmental mutagenesis.
    Loprieno N; Barale R; Baroncelli S; Bauer C; Bronzetti G; Cammellini A; Cercignani G; Cinci A; Leporini C; Nieri R; Nozzolini M; Rossi AM; Serra C; Corsi C
    Mutat Res; 1975 Aug; 29(2):237. PubMed ID: 1186742
    [No Abstract]   [Full Text] [Related]  

  • 40. Proceedings: Changes in the activity of chemical mutagens caused by various compounds.
    Srám RJ
    Mutat Res; 1975 Aug; 29(2):195. PubMed ID: 52838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.